Showing results (11-20 of 105) with videos related to
Sort By:
Pageof 11
Nature Communications|September 28, 2018
A scalable online tool for quantitative social network assessment reveals potentially modifiable social environmental risksAmar Dhand, Charles C White, Catherine Johnson, et al.Journal of Medical Internet Research|June 3, 2025
Longitudinal Digital Phenotyping of Multiple Sclerosis Severity Using Passively Sensed Behaviors and Ecological Momentary Assessments: Real-World EvaluationZongqi Xia, Prerna Chikersal, Shruthi Venkatesh, et al.Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Comparison of B-cell depletion versus natalizumab for treatment of multiple sclerosis: A semi-supervised causal analysisDominic DiSanto, Weijing Tang, Wen Zhu, et al.Neurology. Genetics|August 10, 2016
Complex relation of HLA-DRB1*1501, age at menarche, and age at multiple sclerosis onsetRiley Bove, Alicia S Chua, Zongqi Xia, et al.International Journal of Medical Informatics|May 4, 2020
Automated ICD coding via unsupervised knowledge integration (UNITE)Aaron Sonabend W, Winston Cai, Yuri Ahuja, et al.Medrxiv : the Preprint Server for Health Sciences|March 4, 2025
Circulating cell-free DNA methylation profiles as noninvasive multiple sclerosis biomarkers: A proof-of-concept studyHailu Fu, Kevin Huang, Wen Zhu, et al.Neurology and Therapy|May 22, 2022
Patterns of Utilization and Expenditure Across Multiple Sclerosis Disease-Modifying Therapies: A Retrospective Cohort Study Using Claims Data from a Commercially Insured Population in the United States, 2010-2019Wen Zhu, Xiaoyu Tang, Rock A Heyman, et al.JMIR Mental Health|July 18, 2022
Predicting Multiple Sclerosis Outcomes During the COVID-19 Stay-at-home Period: Observational Study Using Passively Sensed Behaviors and Digital PhenotypingPrerna Chikersal, Shruthi Venkatesh, Karman Masown, et al.JAMA Network Open|November 16, 2021
Comparison of Dimethyl Fumarate vs Fingolimod and Rituximab vs Natalizumab for Treatment of Multiple SclerosisJue Hou, Nicole Kim, Tianrun Cai, et al.Medrxiv : the Preprint Server for Health Sciences|January 7, 2025
Aging-dependent Change in Th17 and Cytokine Response in Multiple SclerosisWen Zhu, Shankar Revu, Chenyi Chen, et al.Pageof 11